Rare Cancers – more common than you think
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
26 Jun 2015
RCE Patient Advocates course on the Methodology of clinical studies in rare cancers
University of Milan, 20 July 2015The meeting is addressed to around 100 European Patient Advocates with a strong interest in rare cancers and acting...
22 Jun 2015
Updated MAC-NPC meta-analysis: concomitant chemotherapy to radiotherapy improves survival in locoregionally advanced nasopharyngeal carcinoma
Results of the updated Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group meta-analysis of individual patient data...
04 Jun 2015
Press Release: Workshop on chordoma discusses challenges of drug development for rare cancers
EMA, ESMO and RCE joint workshop on chordoma as a model for very rare cancers